{"entity":{"id":"idea-fund-device-technique-registry","kind":"idea","name":"Mandatory staged registries for new surgical techniques before wide adoption","aka":[],"tldr":"New operations and surgical devices spread by enthusiasm before evidence, as robotic prostatectomy, minimally invasive radical hysterectomy and HIPEC did. Every new cancer surgical technique would follow the IDEAL framework, with a prospective registry from first use, defined triggers for a randomised comparison, and payment conditional on registry participation until assessment is complete.","summary":"Regulators and payers require that new cancer surgical techniques and devices follow the IDEAL framework (idea, development, exploration, assessment, long-term study), with a prospective registry from first use, defined triggers for moving to a randomised comparison, and reimbursement conditional on registry participation until assessment is complete. Devices already need regulatory clearance but techniques need none, and both diffuse before evidence exists (robotic prostatectomy, minimally invasive radical hysterectomy, cytoreductive surgery with HIPEC). Registries also produce the learning-curve and volume data needed for credentialling.","asOf":"2026-09-08","links":[{"label":"IDEAL Collaboration","url":"https://www.ideal-collaboration.net/"},{"label":"ACS NSQIP","url":"https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/"}],"tags":[],"related":["idea-fund-surgical-ai-robotics-evaluation","idea-fund-device-and-technique-translation-fund","idea-fund-surgical-video-registry","prostate-roadmap","idea-prostate-per-lesion-mri-audit-before-focal-treatment"],"cancers":["cervical","prostate","colorectal"],"sections":[],"technologies":["robotic-surgery","hipec","hifu-histotripsy"],"targets":[],"drugs":[],"companies":["intuitive-surgical"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-surgery-radiation-innovation","b-real-world-evidence"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Mandatory staged registries reduce the time from first use to a randomised or IDEAL stage 3 comparison for new cancer surgical techniques from more than a decade to under five years, and detect harmful diffusion (as with minimally invasive radical hysterectomy) before it becomes standard.","rationale":"The LACC trial found worse survival with minimally invasive radical hysterectomy after the technique had spread for years without randomised evidence; national joint replacement registries have detected failing implants years before regulators. Coverage-with-evidence-development has worked for several devices in the US and UK.","test":"Pilot in one country for three new techniques or devices, measuring registry completeness, time to comparative evidence and the frequency of adoption decisions changed by registry data.","maturity":"early-clinical","actor":"regulator","cost":"medium","horizonYears":3},"route":"/ideas/idea-fund-device-technique-registry/","neighbours":{"idea":[{"id":"idea-fund-device-and-technique-translation-fund","kind":"idea","name":"A translation fund for academic surgical devices and radiotherapy technology","route":"/ideas/idea-fund-device-and-technique-translation-fund/"},{"id":"idea-fund-surgical-video-registry","kind":"idea","name":"A video-based surgical quality registry linking assessed skill to cancer outcomes","route":"/ideas/idea-fund-surgical-video-registry/"},{"id":"idea-fund-surgical-ai-robotics-evaluation","kind":"idea","name":"An independent evaluation unit for surgical robots and AI, paid on evidence","route":"/ideas/idea-fund-surgical-ai-robotics-evaluation/"},{"id":"idea-fund-ablation-versus-surgery-trials","kind":"idea","name":"Device-agnostic public trials of ablation technologies against surgery","route":"/ideas/idea-fund-ablation-versus-surgery-trials/"},{"id":"idea-fund-surgical-outcomes-public-reporting","kind":"idea","name":"Public risk-adjusted outcome reporting for cancer surgery to drive centralisation","route":"/ideas/idea-fund-surgical-outcomes-public-reporting/"},{"id":"idea-prostate-per-lesion-mri-audit-before-focal-treatment","kind":"idea","name":"Publish a per-lesion miss rate for every prostate MRI service before it is allowed to guide focal treatment","route":"/ideas/idea-prostate-per-lesion-mri-audit-before-focal-treatment/"}],"roadmap":[{"id":"prostate-roadmap","kind":"roadmap","name":"Prostate cancer roadmap: from Huggins and the discovery that a cancer can depend on a hormone, through the PSA epidemic and what it cost, the androgen receptor drugs, the DNA repair subset and PSMA, to a 2032 registry watch","route":"/roadmaps/prostate-roadmap/"}],"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"technology":[{"id":"hifu-histotripsy","kind":"technology","name":"Focused ultrasound & histotripsy","route":"/technologies/hifu-histotripsy/"},{"id":"hipec","kind":"technology","name":"HIPEC / PIPAC (intraperitoneal chemotherapy)","route":"/technologies/hipec/"},{"id":"robotic-surgery","kind":"technology","name":"Robotic & minimally invasive surgery","route":"/technologies/robotic-surgery/"}],"company":[{"id":"intuitive-surgical","kind":"company","name":"Intuitive Surgical","route":"/companies/intuitive-surgical/"}],"bottleneck":[{"id":"b-surgery-radiation-innovation","kind":"bottleneck","name":"Surgery and radiotherapy cure most, get least","route":"/bottlenecks/b-surgery-radiation-innovation/"},{"id":"b-real-world-evidence","kind":"bottleneck","name":"Weak real-world evidence and registries","route":"/bottlenecks/b-real-world-evidence/"}]}}